Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2005
07/28/2005WO2005020890A3 Multiplexed molecular beacon assay for detection of pathogens
07/28/2005WO2005009366A3 Restoring vascular function
07/28/2005WO2005003289A3 Ap1 amine oxidase variants
07/28/2005WO2004108895A3 Humanized antibodies that recognize beta amyloid peptide
07/28/2005WO2004069189A3 Methods of assessment of drug metabolizing enzymes
07/28/2005WO2004050900A3 Compositions, splice variants and methods relating to colon specific genes and proteins
07/28/2005WO2004037977A3 Use of chimeric nucleases to stimulate gene targeting
07/28/2005WO2004035806A3 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene
07/28/2005WO2003103597A3 Methods of diagnosing & treating diabetes and insulin resistance
07/28/2005WO2003094088A8 Mouse olfactory receptor gene superfamily specification
07/28/2005WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
07/28/2005US20050166272 Double stranded RNA sequences for use as models in defining and determining sequence complement necessary for RNA interfering activity; wreck and check mutational analysis; blocking agents
07/28/2005US20050165226 Preparing oligonucleotides having phosphorothioate internucleoside linkage; using phenylacetyl disulfide reagent in a simplified solvent system to produce modified oligonucleotides; antiviral agents; antisense agents
07/28/2005US20050165224 Inhibition of penicillin resistance in s. pneumoniae
07/28/2005US20050164974 Ligand is covalently linked to polyoxyethylene glycol having specific binding affinity for vascular endothelial growth factor; SELEX method; improved pharmacokinetics
07/28/2005US20050164970 Method for treating prostate cancer using siRNA duplex for androgen receptor
07/28/2005US20050164969 Method of extending life span
07/28/2005US20050164968 RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)
07/28/2005US20050164966 Aging, cancer, autoimmune diseases, inflammatory/allergic diseases
07/28/2005US20050164965 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent
07/28/2005US20050164962 Method for the identification of tissue-specific regulatory sequences
07/28/2005US20050164933 Method of reducing injury to mammalian cells
07/28/2005US20050164410 Device which utilizes electrochemiluminescence at electrode surface to monitor binding of preferential particles; high throughput assay
07/28/2005US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection
07/28/2005US20050164349 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex
07/28/2005US20050164301 Low density lipoprotein/epidermal growth factor conjugate; directed protein evolution
07/28/2005US20050164292 Efficient synthesis of protein-oligonucleotide conjugates
07/28/2005US20050164287 Nucleic acid ladders
07/28/2005US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders
07/28/2005US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same
07/28/2005US20050164278 Breast cancer specific genes (BSG) and diagnosing/preventing cell proliferative disorders; immunotherapy; paramagnetic imaging
07/28/2005US20050164277 Novel human hemicentin proteins and polynucleotides encoding the same
07/28/2005US20050164276 Nucleotide sequences coding serine protease like polypeptides for use in diagnosis and treatment of infection, diabetes, obesity and infertility
07/28/2005US20050164275 Phosphodiesterases
07/28/2005US20050164268 Oncology diagnosis; gene overexpression/underexpression; tumor suppressor genes
07/28/2005US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/28/2005US20050164265 Single stranded DNA binding proteins from archaea and uses therefor
07/28/2005US20050164258 Solid phase combinatorial synthesis; deprotecting via acid generator
07/28/2005US20050164254 Compositions and their uses directed to metabolic proteins
07/28/2005US20050164250 Compositions and methods for the diagnosis and treatment of tumor
07/28/2005US20050164249 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography
07/28/2005US20050164246 Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns
07/28/2005US20050164235 Modified iRNA agents
07/28/2005US20050164231 Probe composition for modeling prognostic outcomes for cell proliferative disorders; computer models for disease
07/28/2005US20050164215 Methods for rapid purification of nucleic acids for subsquent analysis by mass spectrometery by solution capture
07/28/2005US20050164212 Modulation of gene expression using DNA-RNA hybrids
07/28/2005US20050164210 Regulated polymerase III expression systems and related methods
07/28/2005US20050164208 Storage of genetic information
07/28/2005US20050164207 Method of oligonucleotide synthesis
07/28/2005US20050164206 For use in gene therapy
07/28/2005US20050164201 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof
07/28/2005US20050164194 Growth regulating proteins
07/28/2005US20050164184 Hybridization portion control oligonucleotide and its uses
07/28/2005US20050164170 Neurovirulent strain of the west nile virus and uses thereof
07/28/2005US20050163795 IHNV G protein for immune stimulation
07/28/2005US20050163788 Prevention and treatment of amyloidogenic disease
07/28/2005US20050163772 B7S1: an immune modulator
07/28/2005US20050163766 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/28/2005US20050163755 Methods and compositions related to 1-caldesmon
07/28/2005US20050161331 loading molecules into matrices, then applying an assymetric electric field to separate the molecules according to size and collecting the separated molecules at locations along the matrices
07/28/2005CA2551462A1 Methods for nucleic acid isolation and kits using solid phase material
07/28/2005CA2551453A1 Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
07/28/2005CA2551392A1 Methods of expressing heterologous protein in plant seeds using monocot non seed-storage protein promoters
07/28/2005CA2551156A1 Methods for nucleic acid isolation and kits using a microfluidic device and sedimenting reagent
07/28/2005CA2551126A1 Toxin complex proteins and genes from xenorhabdus bovienii
07/28/2005CA2551082A1 Hiv gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
07/28/2005CA2547511A1 Recombinant icosahedral virus like particle production in pseudomonads
07/27/2005WO2005067410A2 Synthetic nucleic acids from aquatic species
07/27/2005EP1557475A1 Storage of genetic information
07/27/2005EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them
07/27/2005EP1557424A1 Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues
07/27/2005EP1557173A1 Soluble CTLA4 mutant molecules and uses thereof
07/27/2005EP1556510A2 Oligonucleotide analogues for detecting and analyzing nucleic acids
07/27/2005EP1556405A2 Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease
07/27/2005EP1556403A2 Multimeric protein engineering
07/27/2005EP1556402A2 In vivo gene silencing by chemically modified and stable sirna
07/27/2005EP1556325A1 Anthraquinone quencher dyes, their methods of preparation and use
07/27/2005EP1556072A2 Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
07/27/2005EP1556069A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
07/27/2005CN1646702A Protein carrier system for therapeutic oligonucleotides
07/27/2005CN1646688A Growth regulating proteins
07/27/2005CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
07/27/2005CN1646097A Chemosensitizing with liposomes containing oligonucleotides
07/27/2005CN1646006A Novel VIP3 toxins and methods of use
07/27/2005CN1645148A Reagent box for inspecting infection of swine pleuropneumonia actinomyces
07/27/2005CN1644686A High yielded strain of mammalia influenza virus, its recommbined strains and preparation and use thereof
07/27/2005CN1644585A Covalently linked oligonucleotide minor grove binder conjugates
07/27/2005CN1212401C Plant virus satellite DNA beta molecule, infectivity clone and method for preparing expression carrier
07/27/2005CN1212334C Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use
07/27/2005CN1212332C Preparation method of ribonucleic acid
07/27/2005CN1212331C Process for extracting potato virus RNA
07/27/2005CA2555509A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
07/27/2005CA2525582A1 Synthetic nucleic acids from aquatic species
07/26/2005US6921849 Dwarfism genes and dwarf plants
07/26/2005US6921818 Using silyl compositions that can be directly coupled, or coupled through linking group, to compound of interest, preferably to oligomer at end of oligomer synthesis; silicon atom includes 1-3 sidechains that function as capture tags
07/26/2005US6921817 Methods for simultaneous isolation of biologically active transcription factors and DNA
07/26/2005US6921645 Antibodies to chemokine β-4
07/26/2005US6921643 Using template directed dye termination and fluorescence polarization detection to identify pine species containing restriction fragment length polymorphism associated with altered lignin composition
07/26/2005US6921640 Labeling nucleotide sequences; obtain nucleotide sequences, incubate with primer, amplify, transcribe sequences, cleave sequences, incubate with label, recover labeled nucleotide sequences
07/26/2005US6921638 Hydrogel-based microarray signal amplification methods and devices therefor